These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7537400)

  • 41. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E; Ward KN; Szydlo R; Goldman JM
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Detection of cytomegalovirus infection in renal transplant recipients in Korea.
    Kahng KW; Kang CM; Kwak JY
    Transplant Proc; 1996 Jun; 28(3):1507. PubMed ID: 8658762
    [No Abstract]   [Full Text] [Related]  

  • 43. [Effectiveness of preemptive therapy with ganciclovir in recipients of renal transplants at high risk (R-/D+) for the development of cytomegalovirus disease].
    Aranda-Verástegui F; Alberú J; Soto-Ramírez LE; González-Aguirre H; Muñoz Trejo T; Mancilla E; Díliz H; Correa-Rotter R; Sierra-Madero J
    Rev Invest Clin; 2002; 54(3):198-203. PubMed ID: 12183888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management of cytomegalovirus infection in high-risk recipients after renal transplantation: prophylaxis by hyperimmunoglobulins or DHPG treatment?
    Tenschert W; Gonnermann D; Meyer-Moldenhauer WH; Cremaschi L; Huland H
    Transplant Proc; 1993 Dec; 25(6):3256-8. PubMed ID: 8266533
    [No Abstract]   [Full Text] [Related]  

  • 45. Management of cytomegalovirus infection and disease after solid-organ transplantation.
    van der Bij W; Speich R
    Clin Infect Dis; 2001 Jul; 33 Suppl 1():S32-7. PubMed ID: 11389520
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective study of the incidence, timing, significance, risk factors, and outcome of cytomegalovirus infection in liver transplant patients with double-drug immunosuppression and no prophylactic antiviral therapy.
    Sanchez-Turrión V; Cuervas-Mons V; Portero F; Barrios C; Garrido A; Albillos A
    Transplant Proc; 1993 Apr; 25(2):1786. PubMed ID: 8385824
    [No Abstract]   [Full Text] [Related]  

  • 47. Positive donor cytomegalovirus IgG status as a major risk factor for liver allograft recipient infection.
    Neumann UP; Knoop M; Langrehr JM; Jonas S; Bechstein WO; Lang M; Neuhaus P
    Transplant Proc; 1997 Nov; 29(7):2859-60. PubMed ID: 9365592
    [No Abstract]   [Full Text] [Related]  

  • 48. Serum thymidine-kinase and cytomegalovirus-specific antibodies after renal transplantation.
    Tufveson G; Tötterman TH; Källander CF; Hagström A; Gronowitz JS
    Transplant Proc; 1988 Jun; 20(3):405-7. PubMed ID: 2837850
    [No Abstract]   [Full Text] [Related]  

  • 49. Human herpesvirus 7 primary infection in kidney transplant recipients.
    Antón A; Cervera C; Pumarola T; Moreno A; Benito N; Linares L; Esteva C; Cofán F; Jiménez de Anta MT; Marcos MA
    Transplantation; 2008 Jan; 85(2):298-302. PubMed ID: 18212637
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of cytomegalovirus infection with human leukocyte antigen genotypes in recipients after allogeneic liver transplantation.
    Fan J; Meng XQ; Yang MF; Zhou L; Chen XM; Hu MJ; Fan WW; Ma WH; Li LJ
    Hepatobiliary Pancreat Dis Int; 2006 Feb; 5(1):34-8. PubMed ID: 16481279
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Congenital, generalized cytomegalovirus infection. Follow-up and therapeutic strategy with ganciclovir].
    Rezanka E; Ploier R; Emhofer B; Emhofer J
    Padiatr Padol; 1993; 28(6):153-5. PubMed ID: 8302621
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CMV infection after kidney transplantation in children.
    Lehnert A; Niaudet P; Broyer M
    Transplant Proc; 1996 Oct; 28(5):2805. PubMed ID: 8908068
    [No Abstract]   [Full Text] [Related]  

  • 53. Influence of cytomegalovirus antibody status on graft survival in renal transplantation.
    Fauchald P; Leivestad T; Rollag H; Albrechtsen D; Sødal G
    Transplant Proc; 1994 Jun; 26(3):1725. PubMed ID: 8030103
    [No Abstract]   [Full Text] [Related]  

  • 54. Changing impact of cytomegalovirus in liver transplantation -- a single centre experience of more than 1000 transplantations without ganciclovir prophylaxis.
    Seehofer D; Rayes N; Neumann UP; Meisel H; Oettle H; Nüssler NC; Jonas S; Langrehr JM; Neuhaus P
    Transpl Int; 2005 Aug; 18(8):941-8. PubMed ID: 16008744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Follow-up of 28 HCMV seropositive renal-transplant recipients: comparison of clinical, biological and virological parameters in the groups of treated versus untreated infected patients.
    Kamar N; Mengelle C; Yahyaoui S; Sandres-Sauné K; Durand D; Izopet J; Rostaing L
    J Clin Virol; 2005 May; 33(1):35-42. PubMed ID: 15797363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Circulating immunocomplexes in patients after kidney transplantation in relation to infection and rejection].
    Matl I; Hasková V; Kaslík J; Kocandrle V; Seeman J
    Cas Lek Cesk; 1983 Feb; 122(7):196-9. PubMed ID: 6299568
    [No Abstract]   [Full Text] [Related]  

  • 57. [The effect of herpesvirus infections on the results of a kidney allograft].
    Voĭlokova RIa; Posevaia TA; Moĭsiuk IaG; Shabalina NV; Barinskiĭ IF
    Vopr Virusol; 1992; 37(4):204-6. PubMed ID: 1335192
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does acute rejection correlate with infection in liver transplantation?
    Höckerstedt K; Butrón T; Salmela K; Ahonen J; Eklund B; Isoniemi H; Holmberg C; Kyllönen L; Lautenschlager I
    Transplant Proc; 1992 Feb; 24(1):296-7. PubMed ID: 1311475
    [No Abstract]   [Full Text] [Related]  

  • 59. Live cytomegalovirus vaccination of healthy volunteers: eight-year follow-up studies.
    Stern H
    Birth Defects Orig Artic Ser; 1984; 20(1):263-9. PubMed ID: 6329366
    [No Abstract]   [Full Text] [Related]  

  • 60. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease.
    Strandberg TE; Pitkala KH; Tilvis RS
    JAMA; 2009 Jan; 301(4):380-2. PubMed ID: 19176439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.